Evidence map›Paper›PMID 35904727›Full record

ArticleJournal of cancer survivorship : research and practice2024

COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors.

Adana A M Llanos, Angela J Fong, Nabarun Ghosh, Katie A Devine, Denalee O'Malley, Lisa E Paddock, Elisa V Bandera, Shawna V Hudson, Andrew M Evens, Sharon L Manne

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Adana A M Llanos *Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA. al4248@cumc.columbia.edu.
Angela J Fong *Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Nabarun GhoshDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA.
Katie A DevineRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Denalee O'MalleyRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Lisa E PaddockRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Elisa V BanderaDepartment of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Shawna V HudsonRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Andrew M EvensDepartment of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Sharon L ManneDepartment of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Rutgers, The State University of New Jersey · USRutgers Cancer Institute of New JerseyColumbia University Irving Medical Center · US

Funding

Diversity Supplement to Adapting and implementing evidence-based breast cancer follow-up in primary careR01CA257197 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI HUDSON, SHAWNA V. · 2021 to 2025
$3.7M
Optimizing Colorectal Cancer Screening among Patients with Diabetes in Safety-Net Primary Care Settings: Targeting Implementation ApproachesR00CA256043 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI O'MALLEY, DENALEE M. · 2022 to 2024
$656k
Optimizing Colorectal Cancer Screening among Patients with Diabetes in Safety-Net Primary Care Settings: Targeting Implementation ApproachesK99CA256043 · NCI · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI O'MALLEY, DENALEE M. · 2021 to 2022
$313k
THE EFFECT OF ACTIVATED NEUTROPHILS ON RESPIRATORY GLYCOPROTEIN SECRETIONZ01CL000009 · CLC · CLINICAL CENTER · PI SHELHAMER, J H · 1985 to 1989
–
CDC HHS #5NU58DP006279CLC NIH HHS 75N90021D00009NCI NIH HHS R00 CA256043NHLBI NIH HHS 75N92021D00009NIEHS NIH HHS 75N96021D00009ORFDO NIH HHS 75N99021D00009
6 · The paper itself

Abstract

backgroundCancer survivors are particularly vulnerable to adverse COVID-19-related outcomes, but limited data exist on perceptions about the pandemic and related experiences in this group.

methodsIn a cross-sectional analysis of 494 survivors of genitourinary, breast, gynecologic, colorectal, lung, melanoma, or thyroid cancer, from a larger study of cancer survivors in New Jersey, we assessed perceptions about COVID-19 threat, impacts, and experiences using three validated instruments. Responses were coded on a 7-point Likert scale, and subscales were averaged across included items, with higher scores indicating greater perceptions of COVID-19 threat and greater impacts and experiences because of the pandemic. Multivariable linear regression models were used to determine factors associated with higher scores, with Bonferroni correction for multiple comparisons.

resultsIn general, cancer survivors reported moderate perceived COVID-19 threat (3 items, mean score = 3.71 ± 1.97), minimal COVID-19-related impacts (6 items, mean score = 2.23 ± 1.34), and COVID-19-related experiences (7 items, mean score = 2.17 ± 1.00). COVID-19 impact subscale scores varied little (mean subscale score range = 2.09 to 2.29), while COVID-19 experiences subscale scores were quite variable (mean subscale score range = 1.52 to 3.39). Asian American/Pacific Islander race, Black race, female sex, and having more cardiovascular and metabolic and other comorbidities were associated with higher scores on the perceived coronavirus threat questionnaire. Having completed the COVID-19 questionnaires earlier in the pandemic, younger age, American/Pacific Islander race, Hispanic ethnicity, and having more comorbidities were associated with higher scores on the COVID-19 impact questionnaire. Younger age, racial minority status, and having more cardiovascular and metabolic comorbidities were associated with higher scores on the COVID-19 experience questionnaire.

conclusionAmong cancer survivors in New Jersey-a state that experienced high rates of COVID-19 infection-sociodemographic and health-related factors (e.g., race and ethnicity, sex, and multimorbidity) correlate with greater perceptions of COVID-19 threat, impacts, and experiences. IMPLICATIONS FOR CANCER SURVIVORS: Studies are needed to examine the influence of vaccination status on COVID-19 perceptions and identify inequities in clinical outcomes due to pandemic-related disruptions to cancer care.

Indexed as

Cancer SurvivorsCOVID-19NeoplasmsAsian American Native Hawaiian and Pacific IslanderBlack or African AmericanCross-Sectional StudiesFemaleHispanic or LatinoHumansNew JerseyAdultsCancerCancer survivorsCOVID-19 perceptions

Identifiers

PMID35904727
PMCPMC9336177
OpenAlexW4288702371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.